
Vivek Kumar Shrivastava
About Vivek Kumar Shrivastava
Data last updated:
Vivek Kumar Shrivastava is a Director at Lifefirst Pharma Private Limited (since 2021) and Director at Solfirst Technologies India Private Limited (since 2011). The companies operate in Pharma and Service. The 2 current companies with reported revenue have a combined latest revenue of ₹3.25 Cr; the largest is Lifefirst Pharma Private Limited at ₹3.25 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Mar 2021 | 2020 | ₹3.25 Cr (FY 2025) | Active | |
| Director | 12 Mar 2011 | 2011 | ₹4,997 (FY 2025) | Active |
Board colleagues of Vivek Kumar Shrivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajesh Mehta | 01497922 | Lifefirst Pharma Private Limited | Director |
| Rishabh Mehta | 07738680 | Lifefirst Pharma Private Limited | Director |
| Rohit Mehta | 08914431 | Lifefirst Pharma Private Limited | Director |
| Vaishali Vivek Shrivastava | 03301539 | Solfirst Technologies India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Kumar Shrivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Kumar Shrivastava
Vivek Kumar Shrivastava currently holds 2 directorships: Lifefirst Pharma Private Limited (Director, since 10 Mar 2021, revenue ₹3.25 Cr (FY 2025)); Solfirst Technologies India Private Limited (Director, since 12 Mar 2011, revenue ₹4,997 (FY 2025)).
Vivek Kumar Shrivastava was first appointed on 12 Mar 2011 as Director at Solfirst Technologies India Private Limited. The most recent appointment on record is 10 Mar 2021 at Lifefirst Pharma Private Limited.
The 2 current companies of Vivek Kumar Shrivastava that report revenue have a combined latest revenue of ₹3.25 Cr: Lifefirst Pharma Private Limited ₹3.25 Cr (FY 2025); Solfirst Technologies India Private Limited ₹4,997 (FY 2025).
The current boards of Vivek Kumar Shrivastava's companies include Rajesh Mehta (Lifefirst Pharma Private Limited), Rishabh Mehta (Lifefirst Pharma Private Limited), Rohit Mehta (Lifefirst Pharma Private Limited), Vaishali Vivek Shrivastava (Solfirst Technologies India Private Limited).